Cleared Traditional

K233720 - Luminopia (FDA 510(k) Clearance)

Aug 2024
Decision
261d
Days
Class 2
Risk

K233720 is an FDA 510(k) clearance for the Luminopia. This device is classified as a Digital Therapy Device For Amblyopia (Class II - Special Controls, product code QQU).

Submitted by Luminopia, Inc. (Cambridge, US). The FDA issued a Cleared decision on August 8, 2024, 261 days after receiving the submission on November 21, 2023.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.5500. A Digital Therapy Device For Amblyopia Is A Device That Incorporates Dichoptic Presentations On Visual Displays Through Therapeutic Algorithms To Treat Amblyopia Or To Improve Visual Acuity Of Patients With Amblyopia..

Submission Details

510(k) Number K233720 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 21, 2023
Decision Date August 08, 2024
Days to Decision 261 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code QQU - Digital Therapy Device For Amblyopia
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.5500
Definition A Digital Therapy Device For Amblyopia Is A Device That Incorporates Dichoptic Presentations On Visual Displays Through Therapeutic Algorithms To Treat Amblyopia Or To Improve Visual Acuity Of Patients With Amblyopia.